2002Shanghai Journal of Traditional Chinese MedicineRequires access

Clinical Observation of "Liver-Softening Decoction" in Treating Liver Fibrosis Following Chronic Hepatitis

Gang Li

Open publisher page 0 citations

Abstract

To observe the clinical efficacy of Liver-Softening Decoctionin the treatment of liver fibrosis following chronic hepatitis,60 cases were randomized into treatment group with 30 cases treated withLiver-Softening Decoctionand control group with another 30 cases treated withGinseng Trionychidae Pill.They were all treated for 6 months.The clinical symptoms,signs,liver function and indexes related to liver fibrosis were observed.Results:In treatment group,the clinical symptoms and signs improved significantly,especially fatigue that improved more obviously in comparison with control group,P0.01;globulins and γ-globulins improved obviously after treatment,P0.01,also improved much more in comparison with control group,P0.01;HA,IVC,PIIIP and LN also improved remarkably after treatment,P0.01,with a significant difference of HA,LN (P0.01)and IVC (P0.05)in comparison with control group;the total effective rates were 83.33% and 73.33% respectively in treatment group and control group,with a difference between them,P0.05;the excellent rates were 33.33% and 23.33% respectively,with a significant difference between them,P0.01.It is indicated thatLiver-Softening Decoctionhas a better effect on liver fibrosis and cirrhosis arising from virus B hepatitis.

About this research paper

What this paper is about

To observe the clinical efficacy of Liver-Softening Decoctionin the treatment of liver fibrosis following chronic hepatitis,60 cases were randomized into treatment group with 30 cases treated withLiver-Softening Decoctionand control group with another 30 cases treated withGinseng Trionychidae Pill.They were all treated for 6 months.The clinical symptoms,signs,liver function and indexes related to liver fibrosis were observed.Results:In treatment group,the clinical symptoms and signs improved significantly,especially fatigue that improved more obviously in comparison with control group,P0.01;globulins and γ-globulins improved obviously after treatment,P0.01,also improved much more in comparison with control group,P0.01;HA,IVC,PIIIP and LN also improved remarkably after treatment,P0.01,with a significant difference of HA,LN (P0.01)and IVC (P0.05)in comparison with control group;the total effective rates were 83.33% and 73.33% respectively in treatment group and control group,with a difference between them,P0.05;the excellent rates were 33.33% and 23.33% respectively,with a significant difference between them,P0.01.It is indicated thatLiver-Softening Decoctionhas a better effect on liver fibrosis and cirrhosis arising from virus B hepatitis.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

To observe the clinical efficacy of Liver-Softening Decoctionin the treatment of liver fibrosis following chronic hepatitis,60 cases were randomized into treatment group with 30 cases treated withLiver-Softening Decoctionand control group with another 30 cases treated withGinseng Trionychidae Pill.They were all treated for 6 months.The clinical symptoms,signs,liver function and indexes related to liver fibrosis were observed.Results:In treatment group,the clinical symptoms and signs improved significantly,especially fatigue that improved more obviously in comparison with control group,P0.01;globulins and γ-globulins improved obviously after treatment,P0.01,also improved much more in comparison with control group,P0.01;HA,IVC,PIIIP and LN also improved remarkably after treatment,P0.01,with a significant difference of HA,LN (P0.01)and IVC (P0.05)in comparison with control group;the total effective rates were 83.33% and 73.33% respectively in treatment group and control group,with a difference between them,P0.05;the excellent rates were 33.33% and 23.33% respectively,with a significant difference between them,P0.01.It is indicated thatLiver-Softening Decoctionhas a better effect on liver fibrosis and cirrhosis arising from virus B hepatitis.

Key concepts: Medicine, Gastroenterology, Internal medicine, Cirrhosis, Decoction, Liver function, Clinical efficacy, Fibrosis

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical Observation of "Liver-Softening Decoction" in Treating Liver Fibrosis Following Chronic Hepatitis — Research Paper | ScholarLens